Kratom Research Institute

Research · 2026-01-01

Lab Tests Confirm Products Sold as "Kratom Extracts" Are Actually Synthetic 7-OH Drugs

Source: Journal of AOAC International

Why it matters

Consumers buying products labeled as "kratom extracts" may unknowingly be ingesting high-dose synthetic opioids with unknown risks — and no clinical safety data. Mislabeled products may also be distorting adverse event data attributed to natural kratom.

The big picture

The distinction between traditional kratom leaf and synthetic 7-OH is central to the national policy debate. As regulators in dozens of states grapple with how to classify kratom, mislabeled synthetic products may be inflating the risk profile attributed to natural kratom — and the FDA has already asked the DEA to place synthetic 7-OH on Schedule I. This study from BC Institute of Technology provides the first laboratory confirmation that products sold as "kratom extracts" are chemically inconsistent with actual kratom leaf.

Key findings

What they say

The researchers concluded that "the presence of concentrated 7-hydroxymitragynine products in the market masquerading as kratom is misleading, unlawful, and potentially dangerous to the public," and called urgently for regulatory action to remove these "unapproved, synthetic products" from commerce.

Bottom line

Products sold as "kratom extracts" are actually synthetic 7-OH drugs — and laboratory evidence confirms they are chemically, functionally, and biologically distinct from natural kratom leaf.